LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet, coated

dr. reddy's laboratories inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - antihistamine temporarily relieves these symptoms due to hay fever or other respiratory allergies: - runny nose - sneezing - itchy, watery eyes - itching of the nose or throat

XYZAL- levocetirizine dihydrochloride tablet
XYZAL- levocetirizine dihydrochloride solution United States - English - NLM (National Library of Medicine)

xyzal- levocetirizine dihydrochloride tablet xyzal- levocetirizine dihydrochloride solution

physicians total care, inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg - enter section text here xyzal® is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older. xyzal is indicated for the relief of symptoms associated with perennial allergic rhinitis in adults and children 6 months of age and older. xyzal is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of xyzal is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of xyzal, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2) ]. patients with end-stage renal disease (clcr less than 10 ml/min) and patients undergoing hemodialysis children 6 months to 11 years of age with impaired renal function enter section text here pregnancy category b there are no adequate and well-controlled studies in pregnant women. because animal reproduction s

LEVOCETIRIZINE DIHYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet

denton pharma, inc. dba northwind pharmaceuticals - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - 1.2 chronic idiopathic urticaria levocetirizine dihydrochloride is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. the use of levocetirizine dihydrochloride tablet is contraindicated in: 4.1 patients with known hypersensitivity patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)]. 4.2 patients with end-stage renal disease patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis 4.3 pediatric patients with impaired renal function children 6 months to 11 years of age with impaired renal function 8.1 pregnancy risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women ar

LEVOCETIRIZINE DIHYDROCHLORIDE tablet film coated United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet film coated

sun pharma global fze - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

LEVOCETIRIZINE DIHYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet

nostrum laboratories, inc. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

LEVOCETIRIZINE DIHYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet

american health packaging - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

LEVOCETIRIZINE DIHYDROCHLORIDE tablet film coated United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet film coated

lake erie medical dba quality care products llc - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

LEVOCETIRIZINE DIHYDROCHLORIDE- levocetirizine dihydrochloride tablet United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride- levocetirizine dihydrochloride tablet

micro labs limited - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - antihistamine   temporarily relieves these symptoms due to hay fever or other respiratory allergies: - runny nose - sneezing - itchy, watery eyes - itching of the nose or throat - if you have kidney disease - if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

LEVOCETIRIZINE DIHYDROCHLORIDE tablet film coated United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet film coated

winthrop u.s. - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride 5 mg

LEVOCETIRIZINE DIHYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

levocetirizine dihydrochloride tablet, film coated

a-s medication solutions - levocetirizine dihydrochloride (unii: sod6a38aga) (levocetirizine - unii:6u5ea9rt2o) - levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older. the use of levocetirizine dihydrochloride tablets is contraindicated in: patients with known hypersensitivity to levocetirizine or any of the ingredients of levocetirizine dihydrochloride tablets, or to cetirizine. observed reactions range from urticaria to anaphylaxis [see adverse reactions (6.2)] . patients with end-stage renal disease (clcr < 10 ml/min) and patients undergoing hemodialysis. children 6 months to 11 years of age with impaired renal function. risk summary available data from published literature and postmarketing experience with levocetirizine use in pregnant women are insufficient to identify any drug-associated risks of miscarriage, birth defects, or adverse maternal or fetal outcomes. in animal reproduction studies, there was no evidence of fetal harm with administration of levocetirizine by the ora